Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients

AIM: Antineoplastic effect of cisplatin, the first line treatment in non-small cell lung cancer (NSCLC), is hindered by its nephrotoxicity and myelotoxicity. Both low-dose and high-dose regimens are used in the management of NSCLC. The aim of this study is to assess the risk on myelotoxicity and nep...

Descripción completa

Detalles Bibliográficos
Autores principales: Zazuli, Zulfan, Kos, Renate, Veltman, Joris D., Uyterlinde, Wilma, Longo, Cristina, Baas, Paul, Masereeuw, Rosalinde, Vijverberg, Susanne J. H., Maitland-van der Zee, Anke-Hilse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332698/
https://www.ncbi.nlm.nih.gov/pubmed/32670072
http://dx.doi.org/10.3389/fphar.2020.00975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332698/
https://www.ncbi.nlm.nih.gov/pubmed/32670072
http://dx.doi.org/10.3389/fphar.2020.00975

Ejemplares similares